Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1152348

CC(=N/N=c1n(C)ccn1C)/N=N/c1n(C)cc[n+]1C.[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1152353 1.00 HDAC8 (0.33) HDAC8
SCHEMBL3401174 0.99 HDAC8 (0.33) HDAC8
SCHEMBL3401171 0.99 HDAC8 (0.33) HDAC8
Hydrochloric Acid SCHEMBL4806214 0.82 NPSR1 (0.31) HDAC8
SCHEMBL5199374 0.81 HDAC8 (0.31) HDAC8
Hydrochloric Acid SCHEMBL4803365 0.80 KDM4E (0.43)
Hydrochloric Acid SCHEMBL1151781 0.72 HDAC8 (0.33) HDAC8
Hydrochloric Acid SCHEMBL1151788 0.72 HDAC8 (0.33) HDAC8
SCHEMBL483981 0.71 HDAC8 (0.34) HDAC8
SCHEMBL483985 0.71 HDAC8 (0.34) HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11896700-B2 Process for treating keratin fibers using an anhydrous composition comprising a compound of azomethine type comprising two pyrazolopyridine units and an aqueous composition L'OREAL (FR) 2024-02-13 US disclosed
US-20230137804-A1 PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A COMPOUND OF AZOMETHINE TYPE COMPRISING TWO PYRAZOLOPYRIDINE UNITS AND AN AQUEOUS COMPOSITION L'OREAL (FR) 2023-05-04 US disclosed
EP-3474815-B1 PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A COMPOUND OF AZOMETHINE TYPE COMPRISING TWO PYRAZOLOPYRIDINE UNITS AND AN AQUEOUS COMPOSITION OREAL (FR) 2022-03-16 EP disclosed
EP-3475278-B1 (DIS)SYMMETRIC AZOMETHINE-TYPE DIRECT DYE COMPRISING AT LEAST ONE PYRAZOLOPYRIDINE UNIT, PROCESS FOR DYEING KERATIN FIBERS USING THIS DYE OREAL (FR) 2021-12-22 EP disclosed
US-11117864-B2 Use for dyeing keratin fibers of a compound of azomethine type bearing a quinoline-derived unit L'OREAL (FR) 2021-09-14 US disclosed
US-11007131-B2 Dyeing composition comprising a direct dye of triarylmethane structure, and a silicone L'OREAL (FR) 2021-05-18 US disclosed
US-11000464-B2 Dyeing composition at acidic pH comprising a direct dye of triarylmethane structure L'OREAL (FR) 2021-05-11 US disclosed
EP-3393441-B1 DYEING COMPOSITION COMPRISING A DIRECT DYE OF TRIARYLMETHANE STRUCTURE, AND A SILICONE OREAL (FR) 2021-01-20 EP disclosed
EP-3474814-B1 A COMPOUND OF AZOMETHINE TYPE BEARING A QUINOLINE-DERIVED UNIT AND ITS USE FOR DYEING KERATIN FIBERS OREAL (FR) 2020-11-11 EP disclosed
US-20200308117-A1 USE FOR DYEING KERATIN FIBERS OF A COMPOUND OF AZOMETHINE TYPE BEARING A QUINOLINE-DERIVED UNIT L'OREAL (FR) 2020-10-01 US disclosed
US-7678157-B2 Use of an anionic hydrotrope for the colouring of keratinous fibres, composition comprising it and colouring processes employing it L'OREAL S.A. (FR) 2010-03-16 US disclosed
US-20100031453-A1 COMPOSITION FOR DYEING KERATIN FIBRES, COMPRISING A CATIONIC DIAZO DIRECT DYE CONTAINING A 2-IMIDAZOLIUM UNIT L'OREAL S.A. (FR) 2010-02-11 US disclosed
US-20090300856-A1 SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES L'OREAL S.A. (FR) 2009-12-10 US disclosed
US-7582123-B2 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-09-01 US disclosed
US-7569079-B2 Polycationic monochromophoric hydrazone compounds, dye compositions comprising such polycationic compounds and dyeing process using them L'OREAL S.A. (FR) 2009-08-04 US disclosed
US-7559956-B2 Use of a cationic hydrotrope for the direct dyeing of keratinous fibres, composition comprising it and colouring processes employing it L'OREAL S.A. (FR) 2009-07-14 US disclosed
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit L'OREAL S.A. (FR) 2009-02-19 US disclosed
US-20080263785-A1 Polycationic monochromophoric hydrazone compounds, dye compositions comprising such polycationic compounds and dyeing process using them L'OREAL S.A. (FR) 2008-10-30 US disclosed
US-20080086824-A1 Use of a cationic hydrotrope for the direct dyeing of keratinous fibres, composition comprising it and colouring processes employing it L'OREAL S.A. (FR) 2008-04-17 US disclosed
US-20080052840-A1 Use of an anionic hydrotrope for the colouring of keratinous fibres, composition comprising it and colouring processes employing it L'OREAL S.A. (FR) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090300856-A1 SPECIFIC MONOCATIONIC MONOCHROMOPHORIC COMPOUNDS OF HYDRAZONE TYPE COMPRISING A 2-, 4-PYRIDINIUM OR 2-, 4-QUINOLINIUM UNIT, SYNTHESIS THEREOF, DYE COMPOSITIONS CONTAINING THEM, AND METHOD FOR DYEING KERATIN FIBRES KRT18, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-5 HDAC8 1483/4885
US-11896700-B2 Process for treating keratin fibers using an anhydrous composition comprising a compound of azomethine type comprising two pyrazolopyridine units and an aqueous composition KRT18, DPYD, CKAP4 HDAC8 2606/4885
US-11000464-B2 Dyeing composition at acidic pH comprising a direct dye of triarylmethane structure KRT18, TYR, DSG1 HDAC8 593/4885
US-20080052840-A1 Use of an anionic hydrotrope for the colouring of keratinous fibres, composition comprising it and colouring processes employing it KRT18, F12, H1-3 HDAC8 3524/4885
US-20200308117-A1 USE FOR DYEING KERATIN FIBERS OF A COMPOUND OF AZOMETHINE TYPE BEARING A QUINOLINE-DERIVED UNIT KRT18, TUBB1, VIM HDAC8 2567/4885
US-11007131-B2 Dyeing composition comprising a direct dye of triarylmethane structure, and a silicone KRT18, TUBB1, TUBB3 HDAC8 1120/4885
US-11117864-B2 Use for dyeing keratin fibers of a compound of azomethine type bearing a quinoline-derived unit KRT18, TUBB1, VIM HDAC8 2567/4885
US-20230137804-A1 PROCESS FOR TREATING KERATIN FIBERS USING AN ANHYDROUS COMPOSITION COMPRISING A COMPOUND OF AZOMETHINE TYPE COMPRISING TWO PYRAZOLOPYRIDINE UNITS AND AN AQUEOUS COMPOSITION KRT18, DPYD, CKAP4 HDAC8 2606/4885
US-20090044348-A1 Coloring composition comprising at least one azomethine compound with a pyrazolinone unit KRT18, KMO, TMPO HDAC8 3231/4885
US-20080263785-A1 Polycationic monochromophoric hydrazone compounds, dye compositions comprising such polycationic compounds and dyeing process using them KRT18, CKMT1A; CKMT1B, XRCC5 HDAC8 515/4885
US-20080086824-A1 Use of a cationic hydrotrope for the direct dyeing of keratinous fibres, composition comprising it and colouring processes employing it KRT18, H1-0, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HDAC8 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.